Global Growth Hormone Deficiency Market Size, Trends, and Growth Opportunity, By Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, and Others), By Application (Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, and Others), By End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Specialty Pharmacy), By Region and Forecast to 2030.
Global Growth Hormone Deficiency Market
The Growth Hormone Deficiency Market was valued at USD 4187.2 million in 2022 and is expected to reach 6281.30 million by 2030, at a CAGR 3.65% during the forecast period 2023- 2030.
Somatotropin, also known as human growth hormone (HGH), is a peptide hormone that plays a role in cell division, growth stimulation, and cell regeneration in humans. When the pituitary gland is unable to synthesize adequate hGH, human growth hormone (GH) insufficiency results. Recombinant hGH is injected subcutaneously to address this deficit. Humans may have growth hormone insufficiency due to a variety of genetic illnesses, such as Turner syndrome and Prader-Willi syndrome, which results in shorter-than-average height and postponed puberty.
Market Drivers
Increasing growth deficiency anticipates boosting the market growth during the forecast period. The general public's awareness of the usage of synthetic growth hormone therapy has steadily increased. An increase in market growth was brought on by an increase in industrial research into the reasons of growth inadequacies and an improvement in diagnosis rates.
A variety of growth-related conditions, including adult growth hormone deficiency, idiopathic short stature, pediatric growth hormone deficit, and hereditary diseases including Turner syndrome and Prader-Willi syndrome, are enough to increase the market size. One in every 3800 kids in the world has a growth hormone deficiency. One in every 2000 females has Turner syndrome, and one in every 30,000 people has Prader-Willi syndrome. Thus, it is estimated to drive market growth.
Market Restraints
The high cost of treatment is anticipated to hamper the market growth in the coming years. The rising cost of these medications is a hindrance to market expansion. The growth hormone deficiency medications are expensive, making them occasionally unaffordable for lower socioeconomic groups.
Synthetic growth hormone side effects such as fluid retention, joint pain, and muscular soreness are the main barriers to market expansion.
Market Segmentation
The Global Growth Hormone Deficiency Market is divided into Brand, Application, and End User.
Based on Brand, the market is segmented into Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, and Others.
Based on Application, the market is classified into Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, and Others.
Based on End User, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Specialty Pharmacy.
Regional Analysis
The Global Growth Hormone Deficiency Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
North America is estimated to dominate the market growth, due to favorable reimbursement conditions, an established healthcare infrastructure, considerable government initiatives, and rising healthcare awareness. The presence of major firms in the area also facilitates greater access to innovative medications, which benefits the North American market.
Throughout the forecast period, Asia Pacific is anticipated to have a considerable CAGR. By obtaining clearance and launching innovative products, a large market share in potential Asia Pacific nations like China and Japan is a goal for major firms.
Key Players
Various key players are discussed in the Global Growth Hormone Deficiency Market Report including: Novo Nordisk A/S, Pfizer, Inc, Eli Lilly and Company, Novartis AG, Merck KGaA, Roche, and Ferring Pharmaceuticals.
Market Taxonomy
By Brand
• Norditropin
• Genotropin
• Humatrope
• Saizen
• Omnitrope
• Others
By Application
• Growth Hormone (GH) Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small for Gestational Age
• Others
By End User
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Growth Hormone Deficiency Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Growth Hormone Deficiency Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Growth Hormone Deficiency Market, By Brand
5.1 Y-o-Y Growth Comparison, By Brand
5.2 Global Growth Hormone Deficiency Market Share Analysis, By Brand
5.3 Global Growth Hormone Deficiency Market Size and Forecast, By Brand
5.3.1 Norditropin
5.3.2 Genotropin
5.3.3 Humatrope
5.3.4 Saizen
5.3.5 Omnitrope
5.3.6 Others
6 Global Growth Hormone Deficiency Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Growth Hormone Deficiency Market Share Analysis, By Application
6.3 Global Growth Hormone Deficiency Market Size and Forecast, By Application
6.3.1 Growth Hormone (GH) Deficiency
6.3.2 Turner Syndrome
6.3.3 Idiopathic Short Stature
6.3.4 Prader-Willi Syndrome
6.3.5 Small for Gestational Age
6.3.6 Others
7 Global Growth Hormone Deficiency Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Growth Hormone Deficiency Market Share Analysis, By End User
7.3 Global Growth Hormone Deficiency Market Size and Forecast, By End User
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Online Pharmacy
7.3.4 Specialty Pharmacy
8 Global Growth Hormone Deficiency Market, By Region
8.1 Global Growth Hormone Deficiency Market Share Analysis, By Region
8.2 Global Growth Hormone Deficiency Market Size and Forecast, By Region
9 North America Growth Hormone Deficiency Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Growth Hormone Deficiency Market Share Analysis, By Brand
9.3 North America Growth Hormone Deficiency Market Size and Forecast, By Application
9.4 North America Growth Hormone Deficiency Market Size and Forecast, By End User
9.5 North America Growth Hormone Deficiency Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Growth Hormone Deficiency Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Growth Hormone Deficiency Market Share Analysis, By Brand
10.3 Europe Growth Hormone Deficiency Market Size and Forecast, By Application
10.4 Europe Growth Hormone Deficiency Market Size and Forecast, By End User
10.5 Europe Growth Hormone Deficiency Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Growth Hormone Deficiency Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Growth Hormone Deficiency Market Share Analysis, By Brand
11.3 Asia Pacific Growth Hormone Deficiency Market Size and Forecast, By Application
11.4 Asia Pacific Growth Hormone Deficiency Market Size and Forecast, By End User
11.5 Asia Pacific Growth Hormone Deficiency Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Growth Hormone Deficiency Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Growth Hormone Deficiency Market Share Analysis, By Brand
12.3 Latin America Growth Hormone Deficiency Market Size and Forecast, By Application
12.4 Latin America Growth Hormone Deficiency Market Size and Forecast, By End User
12.5 Latin America Growth Hormone Deficiency Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Growth Hormone Deficiency Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Growth Hormone Deficiency Market Share Analysis, By Brand
13.3 Middle East Growth Hormone Deficiency Market Size and Forecast, By Application
13.4 Middle East Growth Hormone Deficiency Market Size and Forecast, By End User
13.5 Middle East Growth Hormone Deficiency Market Size and Forecast, By Country
13.6.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Novo Nordisk A/S
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Pfizer, Inc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Eli Lilly and Company
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Novartis AG
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Merck KGaA
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Roche
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Ferring Pharmaceuticals
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
